Imunon, Inc. is a clinical-stage biotechnology company developing non-viral DNA therapeutics. Its TheraPlas modality delivers DNA-based immunotherapies for solid tumors, with lead candidate IMNN-001, an IL-12 plasmid therapy for advanced ovarian cancer currently in Phase 3 trials (OVATION 3). Its PlaCCine modality targets infectious disease vaccines, including IMNN-101, a completed first-in-human COVID-19 booster vaccine study.
expected 2026-12-29
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-31 | 2025-12-31 | 0001493152-26-013850 | EDGAR | 74K words |
| 2025-02-27 | 2024-12-31 | 0001493152-25-008460 | EDGAR | 74K words |
| 2024-03-28 | 2023-12-31 | 0001493152-24-011616 | EDGAR | 74K words |
| 2023-03-30 | 2022-12-31 | 0001493152-23-009604 | EDGAR | 75K words |
| 2022-03-31 | 2021-12-31 | 0001493152-22-008277 | EDGAR | 106K words |
| 2021-03-19 | 2020-12-31 | 0001493152-21-006382 | EDGAR | — |
| 2020-03-25 | 2019-12-31 | 0001493152-20-004717 | EDGAR | — |
| 2019-03-29 | 2018-12-31 | 0001493152-19-004184 | EDGAR | — |
| 2018-03-27 | 2017-12-31 | 0001437749-18-005539 | EDGAR | — |
| 2017-03-24 | 2016-12-31 | 0001437749-17-005235 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-11 | 2026-06-30 | 0001493152-26-036991 | EDGAR | 30K words |
| 2025-11-13 | 2025-09-30 | 0001493152-25-022120 | EDGAR | 26K words |
| 2025-08-05 | 2025-06-30 | 0001493152-25-011598 | EDGAR | 26K words |
| 2025-05-12 | 2025-03-31 | 0001641172-25-009572 | EDGAR | 19K words |
| 2024-11-07 | 2024-09-30 | 0001493152-24-043931 | EDGAR | 27K words |
| 2024-08-14 | 2024-06-30 | 0001493152-24-031916 | EDGAR | 27K words |
| 2024-05-13 | 2024-03-31 | 0001493152-24-018795 | EDGAR | 21K words |
| 2023-11-14 | 2023-09-30 | 0001493152-23-040803 | EDGAR | 31K words |
| 2023-08-10 | 2023-06-30 | 0001493152-23-027457 | EDGAR | 30K words |
| 2023-05-11 | 2023-03-31 | 0001493152-23-016299 | EDGAR | 28K words |
| 2022-11-14 | 2022-09-30 | 0001493152-22-031641 | EDGAR | 33K words |
| 2022-08-15 | 2022-06-30 | 0001493152-22-022599 | EDGAR | 32K words |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-09-29 | 0001493152-26-044792 | EDGAR | 5K words |
| 2026-08-11 | 0001493152-26-036985 | EDGAR | 3K words |
| 2026-08-11 | 0001493152-26-037170 | EDGAR | 1K words |
| 2026-03-31 | 0001493152-26-013816 | EDGAR | 3K words |
| 2026-03-23 | 0001493152-26-012164 | EDGAR | 1K words |
| 2026-02-05 | 0001493152-26-005203 | EDGAR | 8K words |
| 2026-01-07 | 0001493152-26-000841 | EDGAR | 1K words |
| 2025-12-31 | 0001493152-25-029711 | EDGAR | 1K words |
| 2025-11-13 | 0001493152-25-022118 | EDGAR | 4K words |
| 2025-08-28 | 0001493152-25-012417 | EDGAR | 1K words |
405 total filings indexed. 373 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0000749647 |
| Ticker | IMNN |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.imunon.com |
| Listed | 1995-07-24 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/IMNN (~200 tokens, structured JSON with cryptographic provenance)